Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males (2013)

Peer-Reviewed Study · Harrison DE, Strong R, Allison DB, Ames BN, Astle CM, Atamna H, et al. (NIA Interventions Testing Program) · November 19, 2013

Harrison DE et al., 2013-11-19: The NIA Interventions Testing Program's three-site mouse lifespan trial of methylene blue: 28 ppm in diet from 4 months did not change median lifespan in either sex and showed a non-significant 13% fall in male median survival at one site, with only a 6% rise in female maximum lifespan.

Male survival was not affected at any of the three sites, although there was a suggestion (P = 0.07) of a negative effect at TJL, with a 13% decline in median survival.

PMC full text, Results, Methylene blue section

Harrison DE et al., 2013-11-19: The NIA Interventions Testing Program's three-site mouse lifespan trial of methylene blue: 28 ppm in diet from 4 months did not change median lifespan in either sex and showed a non-significant 13% fall in male median survival at one site, with only a 6% rise in female maximum lifespan. Study type: randomised controlled animal lifespan trial, three independent sites (UT Health Science Center San Antonio, University of Michigan, The Jackson Laboratory). N: UM-HET3 genetically heterogeneous mice, several hundred per group across sites. Country: USA. Dose: 28 mg/kg diet (28 ppm), continuous from 4 months of age for life. Route: oral, in feed. Product: methylene blue hydrate, Sigma-Aldrich Cat #66720. Comparator: untreated controls. Funder: NIA AG022303, AG022307, U01 AG022307, P01 AG027956, P30 CA034196 and others. Declared conflicts: none stated. This is the single most important model-organism lifespan test of methylene blue and it did not extend median lifespan. Study type: animal.